Cânceres que ocorrem na gravidez: revisão integrativa

Abstract

The diagnosis of malignant pain during pregnancy raises great concern for the patient and for the medical staff in relation to therapeutic and prognosis. The aim of the study was to identify the major cancers that affect pregnant women and their chemotherapeutic treatment. The sample was composed of eighteen articles, published between 2005 and 2013, in PUBMED and LILACS. With regard to the types of neoplasms seven (38.9%) articles addressed Breast cancer, three (16.7%) leukemia, four (22.2%) Hodgkin lymphoma and non-Hodgkin lymphoma, two (11, 1%) Cervical cancer, two (11.1%) and ovarian cancer (5.5%) Uterine leiomyomas, one (5.5%) Cervical Dysplasia, one (5.5%) cancer Brain and one (5.5%) lung cancer. The therapy used was different for each type of cancer. The integrative review identified that chemotherapy should not be delayed, but can cause major damage to the fetus if it is performed in the first trimester of pregnancy. Radiotherapy, where possible, be avoided at any stage. The group of chemotherapy that affects pregnancy is of antimetabolites and, among these, the worst is methotrexate. Regardless of the treatment chosen special care must be taken to protect the fetus binomial breast.